Abstract
The use of immunomodulators in the treatment of subjects with postvaccinal reactions to TEOVac was investigated. The most effective schemes were shown to be those with the use of viferon or combination of arbidol and licopide. The terms of the response signs cupping off were much shorter vs. the cases treated with polyoxidonium. The immunomodulating factors did not affect the intensity of the immunity to the vaccine virus.
MeSH terms
-
Acetylmuramyl-Alanyl-Isoglutamine / analogs & derivatives*
-
Acetylmuramyl-Alanyl-Isoglutamine / pharmacology
-
Drug Therapy, Combination
-
Humans
-
Immunization / adverse effects
-
Immunologic Factors / pharmacology*
-
Indoles / pharmacology*
-
Interferon alpha-2
-
Interferon-alpha / pharmacology*
-
Piperazines / pharmacology
-
Polymers / pharmacology
-
Recombinant Proteins / pharmacology
-
Smallpox Vaccine / administration & dosage
-
Smallpox Vaccine / adverse effects*
-
Smallpox Vaccine / immunology
-
Tonsillitis* / drug therapy
-
Tonsillitis* / etiology
-
Vaccinia virus / immunology
Substances
-
Immunologic Factors
-
Indoles
-
Interferon alpha-2
-
Interferon-alpha
-
Piperazines
-
Polymers
-
Recombinant Proteins
-
Smallpox Vaccine
-
glikopin
-
Acetylmuramyl-Alanyl-Isoglutamine
-
azoximer bromide
-
umifenovir